Wave Total Liab from 2010 to 2025

WVE Stock  USD 9.59  0.08  0.83%   
Wave Life's Total Liabilities is increasing over the years with slightly volatile fluctuation. Total Liabilities is expected to dwindle to about 134.8 M. Total Liabilities is the total amount of all liabilities that Wave Life Sciences has, including both short-term and long-term liabilities. View All Fundamentals
 
Total Liabilities  
First Reported
2013-12-31
Previous Quarter
216.9 M
Current Value
142.7 M
Quarterly Volatility
92.1 M
 
Yuan Drop
 
Covid
Check Wave Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Wave Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.1 M, Interest Expense of 1.8 M or Selling General Administrative of 36.3 M, as well as many indicators such as Price To Sales Ratio of 15.0, Dividend Yield of 0.0 or PTB Ratio of 15.68. Wave financial statements analysis is a perfect complement when working with Wave Life Valuation or Volatility modules.
  
Check out the analysis of Wave Life Correlation against competitors.

Latest Wave Life's Total Liab Growth Pattern

Below is the plot of the Total Liab of Wave Life Sciences over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. Wave Life's Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Wave Life's overall financial position and show how it may be relating to other accounts over time.
Total Liab10 Years Trend
Slightly volatile
   Total Liab   
       Timeline  

Wave Total Liab Regression Statistics

Arithmetic Mean102,228,682
Geometric Mean44,030,339
Coefficient Of Variation91.12
Mean Deviation86,583,557
Median134,804,909
Standard Deviation93,150,584
Sample Variance8677T
Range226.5M
R-Value0.79
Mean Square Error3497.3T
R-Squared0.62
Significance0.0003
Slope15,453,341
Total Sum of Squares130155.5T

Wave Total Liab History

2025134.8 M
2024142.7 M
2023227.4 M
2022191.5 M
2021174.5 M
2020196.5 M
2019220.5 M

About Wave Life Financial Statements

Wave Life stakeholders use historical fundamental indicators, such as Wave Life's Total Liab, to determine how well the company is positioned to perform in the future. Although Wave Life investors may analyze each financial statement separately, they are all interrelated. For example, changes in Wave Life's assets and liabilities are reflected in the revenues and expenses on Wave Life's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Wave Life Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Liabilities142.7 M134.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Wave Life Sciences is a strong investment it is important to analyze Wave Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Wave Life's future performance. For an informed investment choice regarding Wave Stock, refer to the following important reports:
Check out the analysis of Wave Life Correlation against competitors.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Wave Life. If investors know Wave will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Wave Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.70)
Revenue Per Share
0.783
Quarterly Revenue Growth
1.882
Return On Assets
(0.22)
Return On Equity
(0.73)
The market value of Wave Life Sciences is measured differently than its book value, which is the value of Wave that is recorded on the company's balance sheet. Investors also form their own opinion of Wave Life's value that differs from its market value or its book value, called intrinsic value, which is Wave Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Wave Life's market value can be influenced by many factors that don't directly affect Wave Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Wave Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Wave Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Wave Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.